Top View
- Crosslinking of CD44 on Human Osteoblastic Cells Upregulates ICAM
- Role of CD44 in the Reaction of Vascular Smooth Muscle Cells to Arterial Wall Injury
- Polysialic Acid Governs T-Cell Development by Regulating Progenitor Access to the Thymus
- Effects of B Cell–Activating Factor on Tumor Immunity
- Response to Proinflammatory Cytokines Cell-Activating Factor Of
- Targeting the Stromal Pro-Tumoral Hyaluronan-CD44 Pathway in Pancreatic Cancer
- CD44 Sorted Cells Have an Augmented Potential
- Leukocyte Marker CD43 Promotes Cell Growth in Co-Operation with Β-Catenin in Non-Hematopoietic Cancer Cells
- CD74 Is a Novel Transcription Regulator
- The Adhesion Receptor CD44 Promotes Atherosclerosis by Mediating Inflammatory Cell Recruitment and Vascular Cell Activation
- CD44 Alternative Splicing Is a Sensor of Intragenic DNA Methylation in Tumors
- The Biology and Role of CD44 in Cancer Progression: Therapeutic Implications Chen Chen1, Shujie Zhao2, Anand Karnad2,4 and James W
- Syndecans and CD44 in Normal Human Keratinocyte Cultures: Modulation with Medium Composition and All-Trans Retinoic Acid M-A
- Immune Cell Guide
- Redox Regulation in Stem-Like Cancer Cells by CD44 Variant Isoforms
- Β2 Integrins—Multi-Functional Leukocyte Receptors in Health and Disease
- CD44-Mediated Activation of Α5β1-Integrin, Cortactin and Paxillin
- Integrin Alpha-2 and Beta-1 Expression Increases Through
- O-Glycans Direct Selectin Ligands to Lipid Rafts on Leukocytes
- Regulation of CD45 Engagement by the B-Cell Receptor CD22 DENNIS SGROI*Tt, GARY A
- Genomics Research
- Epratuzumab Trogocytosis of Multiple B-Cell Surface Markers by CD22
- Understanding the Dual Nature of CD44 in Breast Cancer Progression
- De Novo Expression of CD44 Variants in Sporadic and Hereditary Gastric
- Research 1..9
- CD70 As an Actionable Immunotherapeutic Target in Recurrent Glioblastoma
- IL-6 Regulates CD44 Cell Surface Expression on Human Myeloma Cells
- A PCR-Based Method for the Analysis of Human CD44 Splice Products
- CD44 Highcd62llow) and Central (CD44 Highcd62lhigh) Phenotype by an This Information Is Current As Archaeosome Adjuvant Independent of TLR2 of September 25, 2021
- Bladder Cancer Metastasis Induced by Chronic Everolimus Application Can Be Counteracted by Sulforaphane in Vitro
- Acute Myeloid Leukemia Stem Cells: the Challenges of Phenotypic Heterogeneity
- HHS Public Access Author Manuscript
- Interplay Between Cell-Surface Receptors and Extracellular Matrix in Skin
- Regulation of IMP3 by EGFR Signaling and Repression by ERΒ: Implications for Triple-Negative Breast Cancer
- Inducible Formation of Leading Cells Driven by CD44 Switching Gives Rise to Collective Invasion
- Prediction of Key Genes and Pathways Involved in Trastuzumab-Resistant
- ORIGINAL RESEARCH Preclinical Evaluation of an Engineered Scfv
- To Antigen Pathway Blocks a Subset of B Cell Responses Inhibition of The
- Understanding Glioblastoma Biomarkers: Knocking a Mountain with a Hammer
- Adhesion Deregulation in Acute Myeloid Leukaemia
- A1242-CD164 Polyclonal Antibody
- Targeting MUC1-C Inhibits TWIST1 Signaling in Triple-Negative Breast
- Lethal T Cell Immunodeficiency Induced by Chronic Costimulation Via CD27-CD70 Interactions Kiki Tesselaar1,2,*, Ramon Arens1–3,*, Gijs M.W
- 3901.Full.Pdf
- Leukocyte Beta2-Integrins
- Synovial Cells Up-Regulates VCAM-1 Cross-Linking of CD44 On
- Serine/Threonine-Protein Kinase 24 Is an Inhibitor of Gastric Cancer Metastasis
- Mapping Lung Cancer Epithelial-Mesenchymal Transition States and Trajectories with Single-Cell Resolution